Avobenzone; ecamsule; octocrylene - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for avobenzone; ecamsule; octocrylene and what is the scope of freedom to operate?
Avobenzone; ecamsule; octocrylene
is the generic ingredient in four branded drugs marketed by Loreal Usa and is included in four NDAs. Additional information is available in the individual branded drug profile pages.One supplier is listed for this compound.
Summary for avobenzone; ecamsule; octocrylene
US Patents: | 0 |
Tradenames: | 4 |
Applicants: | 1 |
NDAs: | 4 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 1 |
DailyMed Link: | avobenzone; ecamsule; octocrylene at DailyMed |
Recent Clinical Trials for avobenzone; ecamsule; octocrylene
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Food and Drug Administration (FDA) | Phase 1 |
Spaulding Clinical Research LLC | Phase 1 |
US Patents and Regulatory Information for avobenzone; ecamsule; octocrylene
Expired US Patents for avobenzone; ecamsule; octocrylene
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Loreal Usa | ANTHELIOS SX | avobenzone; ecamsule; octocrylene | CREAM;TOPICAL | 021502-001 | Jul 21, 2006 | ⤷ Try a Trial | ⤷ Try a Trial |
Loreal Usa | ANTHELIOS SX | avobenzone; ecamsule; octocrylene | CREAM;TOPICAL | 021502-001 | Jul 21, 2006 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |